New global research shows that chronic kidney disease is climbing the ranks of leading causes of death, while millions of ...

This review synthesizes clinical, genetic, and mechanistic evidence showing that suPAR and related uPAR fragments are ...

Nearly 1 in 7 adults in the United States lives with chronic kidney disease, a condition that often advances quietly until ...

Light intensity activities, like walking or household chores, were linked to a lower risk of death for people with ...

In a clinical practice guideline (CPG) issued by the U.S. Department of Veterans Affairs (VA) and U.S. Department of Defense ...

Disagreement between creatinine and cystatin C kidney tests signals a much higher risk of serious disease and death, ...

Score had temporal stability for patients with stable kidney function, but was responsive for only some with worsening disease.

Chronic kidney disease can quietly reshape a life long before the first lab test comes back abnormal. More than 700 million ...

Post hoc trial findings support aprocitentan’s potential cardiovascular and kidney-protective effects in patients with chronic kidney disease (CKD) with resistant hypertension.

In 2025, the FDA approved six drugs to treat various kidney diseases, including updates for Ozempic and the first approval of ...

The incidence of kidney disease is substantially higher in patients with Down syndrome than in control individuals from the ...